| - SMTL ID
- 5sf3.1
- Ligands
- ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4S)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(1H-pyrazol-3-yl)methyl]-1H-pyrazole-4,5-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sf3.2
- Ligands
- ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4S)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(1H-pyrazol-3-yl)methyl]-1H-pyrazole-4,5-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sf3.3
- Ligands
- ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4S)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(1H-pyrazol-3-yl)methyl]-1H-pyrazole-4,5-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|
| - SMTL ID
- 5sf3.4
- Ligands
- ZINC ION; MAGNESIUM ION; 1-methyl-N~5~-[(4S)-2-phenylimidazo[1,2-a]pyrimidin-7-yl]-N~4~-[(1H-pyrazol-3-yl)methyl]-1H-pyrazole-4,5-dicarboxamide
- Polypeptides
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- Oligo-state
- monomer
|